AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pietrzik, K.
Right arrow Articles by Prinz-Langenohl, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pietrzik, K.
Right arrow Articles by Prinz-Langenohl, R.
Agricola
Right arrow Articles by Pietrzik, K.
Right arrow Articles by Prinz-Langenohl, R.
American Journal of Clinical Nutrition, Vol. 86, No. 5, 1414-1419, November 2007
© 2007 American Society for Nutrition


ORIGINAL RESEARCH COMMUNICATION

Calculation of red blood cell folate steady state conditions and elimination kinetics after daily supplementation with various folate forms and doses in women of childbearing age1,2

Klaus Pietrzik, Yvonne Lamers, Susanne Brämswig and Reinhild Prinz-Langenohl

1 From the Institute of Nutrition and Food Sciences, Pathophysiology of Nutrition, University of Bonn, Bonn, Germany

Background: A maternal red blood cell (RBC) folate concentration > 906 nmol/L is thought to be optimal for lowering the risk of neural tube defects (NTDs) in pregnancy. Whereas the appearance of folate in RBCs has been followed during folic acid supplementation, data on elimination kinetics are not yet available.

Objective: The aim of our investigation was to estimate the steady state conditions and elimination kinetics of folate in RBCs.

Design: Data from 2 randomized, placebo-controlled, double-blind intervention trials were used for kinetic modeling. These studies were performed to investigate the appearance of folate in RBCs in healthy women of childbearing age after different supplementation strategies (study 1: n = 69; 400 µg folic acid/d and 416 µg [6S]-5-methyltetrahydrofolate/d for 24 wk; study 2: n = 21; 800 µg folic acid/d for 16 wk).

Results: For RBC folate concentrations, steady state conditions were not reached after 24 (study 1) and 16 (study 2) wk of folate supplementation. However, with the use of these data, we calculated the biological half-life (t1/2) of RBC folate to be {approx}8 wk. With the application of pharmacokinetic principles, steady state conditions for RBC folate should be reached after 40 wk (t1/2 x 5).

Conclusion: With the use of pharmacokinetic principles, the appearance and elimination kinetics of RBC folate can be calculated on the basis of this t1/2 value.

Key Words: Red blood cell folate • steady state • elimination • kinetics • neural tube defects




This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
E. P Quinlivan
Calculation of steady state conditions and elimination kinetics of red blood cell folate in women of childbearing age after daily supplementation with various forms and doses of folate
Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1537 - 1538.
[Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
Y. Lamers and K. Pietrzik
Reply to EP Quinlivan
Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1538 - 1539.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by The American Society for Nutrition